Ngā hua rapu - Noriko Ihana‐Sugiyama
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan mā Ryotaro Bouchi, Takehiro Sugiyama, Atsushi Goto, Kenjiro Imai, Noriko Ihana‐Sugiyama, Mitsuru Ohsugi, Toshimasa Yamauchi, Takashi Kadowaki, Kohjiro Ueki
I whakaputaina 2021Artigo -
2
Literature Review of Studies Using the National Database of the Health Insurance Claims of Japan (NDB): Limitations and Strategies in Using the NDB for Research mā Maiko Suto, Arisa Iba, Takehiro Sugiyama, Tomoko Kodama, Misa Takegami, Reina Taguchi, Mariko Niino, Ryuji Koizumi, Kimikazu Kashiwagi, Kenjiro Imai, Noriko Ihana‐Sugiyama, Yuichi Ichinose, Kenji Takehara, Hiroyasu Iso
I whakaputaina 2024Revisão
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Alternative medicine
Christian ministry
Computer science
Diabetes mellitus
Drug
Endocrinology
Environmental health
Family medicine
First line
Identifier
Internal medicine
Law
MEDLINE
Medical prescription
Pathology
Pharmacology
Political science
Population
Programming language
Retrospective cohort study
Type 2 diabetes
Unique identifier